chartexchange

CEROW
CERO THERAPEUTICS WTS 29
stockOTCWarrant

EODNov 13, 2026
0.00195USD+11.429%(+0.0002)5,000

CEROW Financials

In Q3 FY 2026 (ended ), CERO THERAPEUTICS WTS 29 (CEROW) reported net income of $4.02M, operating cash flow of −$3.03M, and assets of $1.83M (filed ).

Loading financial statements…